Uncategorized FDA Postpones Advisory Committee Review of Celltrion’s Remicade… Thomas Sullivan Feb 26, 2015 0 Celltrion will have to wait longer than expected for FDA's Advisory Committee to review its application for Remsima, a …
Innovation Drug Price Policy: New Transparency Bill Would Require Drug Companies To… Thomas Sullivan Feb 26, 2015 0 An interesting claim against the pharmaceutical industry (though usually made by only industry's most hardened critics) is that…
